Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease.

W Renner; H Köppel; M Brodmann; E Pabst; Katharina Schallmoser; H Toplak; T C Wascher; E Pilger

Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease.

W Renner, H Köppel, M Brodmann, E Pabst, Katharina Schallmoser (Co-author), H Toplak, T C Wascher, E Pilger

Research output: Contribution to journal › Original Article › peer-review

27 Citations (Web of Science)

Original language	English
Pages (from-to)	20-22
Journal	THROMBOSIS AND HAEMOSTASIS
Volume	83
Issue number	1
Publication status	Published - 2000

Keywords

ACTIVATED PROTEIN-C
COAGULATION-FACTOR-V
MYOCARDIAL-INFARCTION
PROTHROMBIN GENE
VENOUS THROMBOSIS
VASCULAR-DISEASE
YOUNG-WOMEN
RISK FACTOR
RESISTANCE
PREVALENCE

Cite this

Renner, W., Köppel, H., Brodmann, M., Pabst, E., Schallmoser, K., Toplak, H., Wascher, T. C., & Pilger, E. (2000). Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease. THROMBOSIS AND HAEMOSTASIS , 83(1), 20-22.

Renner, W ; Köppel, H ; Brodmann, M et al. / Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease. In: THROMBOSIS AND HAEMOSTASIS 2000 ; Vol. 83, No. 1. pp. 20-22.

@article{6cdad149afaf4d2a93b301e4dfcb9a93,

title = "Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease.",

keywords = "ACTIVATED PROTEIN-C, COAGULATION-FACTOR-V, MYOCARDIAL-INFARCTION, PROTHROMBIN GENE, VENOUS THROMBOSIS, VASCULAR-DISEASE, YOUNG-WOMEN, RISK FACTOR, RESISTANCE, PREVALENCE",

author = "W Renner and H K{\"o}ppel and M Brodmann and E Pabst and Katharina Schallmoser and H Toplak and Wascher, \{T C\} and E Pilger",

year = "2000",

language = "English",

volume = "83",

pages = "20--22",

journal = "THROMBOSIS AND HAEMOSTASIS ",

issn = "0340-6245",

number = "1",

}

Renner, W, Köppel, H, Brodmann, M, Pabst, E, Schallmoser, K, Toplak, H, Wascher, TC & Pilger, E 2000, 'Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease.', THROMBOSIS AND HAEMOSTASIS , vol. 83, no. 1, pp. 20-22.

Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease. / Renner, W; Köppel, H; Brodmann, M et al.
In: THROMBOSIS AND HAEMOSTASIS , Vol. 83, No. 1, 2000, p. 20-22.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease.

AU - Renner, W

AU - Köppel, H

AU - Brodmann, M

AU - Pabst, E

AU - Schallmoser, Katharina

AU - Toplak, H

AU - Wascher, T C

AU - Pilger, E

PY - 2000

Y1 - 2000

KW - ACTIVATED PROTEIN-C

KW - COAGULATION-FACTOR-V

KW - MYOCARDIAL-INFARCTION

KW - PROTHROMBIN GENE

KW - VENOUS THROMBOSIS

KW - VASCULAR-DISEASE

KW - YOUNG-WOMEN

KW - RISK FACTOR

KW - RESISTANCE

KW - PREVALENCE

M3 - Original Article

C2 - 10669148

SN - 0340-6245

VL - 83

SP - 20

EP - 22

JO - THROMBOSIS AND HAEMOSTASIS

JF - THROMBOSIS AND HAEMOSTASIS

IS - 1

ER -

Renner W, Köppel H, Brodmann M, Pabst E, Schallmoser K, Toplak H et al. Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease. THROMBOSIS AND HAEMOSTASIS . 2000;83(1):20-22.